Meet The Team

Dr. Manuela La Montagna

Dr. Manuela La Montagna joins ApconiX’s Safety Science Group as a Senior Scientist, authoring Target Safety Assessments with Dr. Helen Garside. Her expertise in drug discovery, oncology, and safety mechanistics strengthens ApconiX’s carcinogenicity assessments. Manuela earned her BSc in General and Applied Biology from the University of Naples Federico II and her MSc in Molecular Biology from VU University of Amsterdam. She completed her PhD at Cancer Research UK Institute in Manchester, researching AMPKα in non-small cell lung cancer using CRISPR-engineered models and RNA-Seq analysis. At Redx Pharma, she progressed from early oncology and fibrosis drug discovery to translational work on late-stage clinical projects, developing a mitochondrial toxicity assay and leading biomarker strategies.